New drugs trail many old ones in effectiveness against disease

“New drugs trail many old ones in effectiveness against disease.” By Sharon Begley, Reuters.

Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. In the early years, drugs easily beat the placebo: They . . . → Read More: New drugs trail many old ones in effectiveness against disease